These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18307746)

  • 21. Spontaneous myocardial infarction and nitric oxide synthase.
    Tsutsui M; Nakata S; Shimokawa H; Otsuji Y; Yanagihara N
    Trends Cardiovasc Med; 2008 Nov; 18(8):275-9. PubMed ID: 19345314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide "at heart": emerging paradigms after a decade.
    Pelat M; Massion PB; Balligand JL
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):242-8. PubMed ID: 15816328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide pathway in hypertrophied heart: new therapeutic uses of nitric oxide donors.
    Ruiz-Hurtado G; Delgado C
    J Hypertens; 2010 Sep; 28 Suppl 1():S56-61. PubMed ID: 20823718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide and the enigma of cardiac hypertrophy.
    Kempf T; Wollert KC
    Bioessays; 2004 Jun; 26(6):608-15. PubMed ID: 15170858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide production in the sphenoidal sinus by the inducible and constitutive isozymes of nitric oxide synthase.
    Petruson K; Stalfors J; Jacobsson KE; Ny L; Petruson B
    Rhinology; 2005 Mar; 43(1):18-23. PubMed ID: 15844497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of NOS in heart failure: lessons from murine genetic models.
    Mungrue IN; Husain M; Stewart DJ
    Heart Fail Rev; 2002 Oct; 7(4):407-22. PubMed ID: 12379825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways.
    Lin Y; Wang LN; Xi YH; Li HZ; Xiao FG; Zhao YJ; Tian Y; Yang BF; Xu CQ
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):124-30. PubMed ID: 18816294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac neurobiology of nitric oxide synthases.
    Danson EJ; Paterson DJ
    Ann N Y Acad Sci; 2005 Jun; 1047():183-96. PubMed ID: 16093496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of nitric oxide synthases in lung inflammation.
    Esposito E; Cuzzocrea S
    Curr Opin Investig Drugs; 2007 Nov; 8(11):899-909. PubMed ID: 17979023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of beta 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide.
    Birenbaum A; Tesse A; Loyer X; Michelet P; Andriantsitohaina R; Heymes C; Riou B; Amour J
    Anesthesiology; 2008 Dec; 109(6):1045-53. PubMed ID: 19034101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of tashinone on nitric oxide synthase in hypertrophic cardiomyocyte of rats suffered abdominal aorta constriction].
    Li YS; Wang ZH; Yan L; Yong YQ; Wang J; Liang QS; Zheng Z; Yang GT
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1446-50. PubMed ID: 18837353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiomyocytes as effectors of nitric oxide signalling.
    Seddon M; Shah AM; Casadei B
    Cardiovasc Res; 2007 Jul; 75(2):315-26. PubMed ID: 17568574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide synthases in heart failure.
    Carnicer R; Crabtree MJ; Sivakumaran V; Casadei B; Kass DA
    Antioxid Redox Signal; 2013 Mar; 18(9):1078-99. PubMed ID: 22871241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
    McMullen JR; Jennings GL
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):255-62. PubMed ID: 17324134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase 5 inhibitors: are they cardioprotective?
    Reffelmann T; Kloner RA
    Cardiovasc Res; 2009 Jul; 83(2):204-12. PubMed ID: 19474180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
    Oudit GY; Penninger JM
    Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myocardial effects of nitric oxide, NO. Clinical and experimental evidence].
    Heymes C; Swynghedauw B; Samuel JL
    Bull Acad Natl Med; 2005 May; 189(5):893-901; discussion 901. PubMed ID: 16433461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent roles of endothelial nitric oxide synthase in cardiac hypertrophy and chamber dilatation?
    Shah AM
    Cardiovasc Res; 2005 Jun; 66(3):421-2. PubMed ID: 15914104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.